1. Home
  2. PLRX vs ESQ Comparison

PLRX vs ESQ Comparison

Compare PLRX & ESQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • ESQ
  • Stock Information
  • Founded
  • PLRX 2015
  • ESQ 2006
  • Country
  • PLRX United States
  • ESQ United States
  • Employees
  • PLRX N/A
  • ESQ N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • ESQ Commercial Banks
  • Sector
  • PLRX Health Care
  • ESQ Finance
  • Exchange
  • PLRX Nasdaq
  • ESQ Nasdaq
  • Market Cap
  • PLRX 77.3M
  • ESQ 756.3M
  • IPO Year
  • PLRX 2020
  • ESQ 2017
  • Fundamental
  • Price
  • PLRX $1.40
  • ESQ $96.35
  • Analyst Decision
  • PLRX Hold
  • ESQ Hold
  • Analyst Count
  • PLRX 10
  • ESQ 3
  • Target Price
  • PLRX $9.79
  • ESQ $99.00
  • AVG Volume (30 Days)
  • PLRX 1.6M
  • ESQ 171.0K
  • Earning Date
  • PLRX 08-06-2025
  • ESQ 07-24-2025
  • Dividend Yield
  • PLRX N/A
  • ESQ 0.73%
  • EPS Growth
  • PLRX N/A
  • ESQ 13.51
  • EPS
  • PLRX N/A
  • ESQ 5.27
  • Revenue
  • PLRX N/A
  • ESQ $124,132,000.00
  • Revenue This Year
  • PLRX N/A
  • ESQ N/A
  • Revenue Next Year
  • PLRX N/A
  • ESQ $10.72
  • P/E Ratio
  • PLRX N/A
  • ESQ $18.32
  • Revenue Growth
  • PLRX N/A
  • ESQ 14.72
  • 52 Week Low
  • PLRX $1.10
  • ESQ $49.16
  • 52 Week High
  • PLRX $16.10
  • ESQ $101.35
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 54.68
  • ESQ 56.40
  • Support Level
  • PLRX $1.13
  • ESQ $93.57
  • Resistance Level
  • PLRX $1.27
  • ESQ $101.28
  • Average True Range (ATR)
  • PLRX 0.11
  • ESQ 3.23
  • MACD
  • PLRX 0.02
  • ESQ 0.16
  • Stochastic Oscillator
  • PLRX 90.00
  • ESQ 58.99

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company. Through its subsidiary, the company operates as a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. In addition, it operates a payment processing platform through third-party independent sales organizations.

Share on Social Networks: